ERBB2 and breast cancer: Consistent with these concepts, lymphocyte infiltration into breast tumors is correlated with improved overall survival [38], and peripheral blood of breast cancer patients show evidence at both the cellular and humoral level of immunity to antigens (MUC-1 and Her-2/neu) associated with human breast cancer [39], [40].